|
While the
past decade has seen a number of advances in colorectal cancer
screening and treatment, these have yet to translate into an increase
in survival time for those diagnosed with the disease, according
to researchers.
The researchers,
reporting in the American Journal of Gastroenterology, said they
evaluated almost 150,000 cases of colorectal cancer diagnosed
in four three-year blocks: 19861988, 19891991, 19921994,
and 19951997.
They said
the incidence of colorectal cancer in the United States, particularly
among whites, declined over this 12-year period.
But in looking
at one-year, three-year and five-year survival rates for patients
diagnosed with colorectal cancer, the researchers reported that
"no significant differences in survival were seen over time
in whites or blacks.
"The
lack of improvement in survival over time in whites and blacks
indicates that despite advances in screening and treatment, to
date, no survival benefit has occurred," the researchers
concluded.
Other
Sources: American Journal of Gastroenterology
|